Preoperative tranexamic acid does not reduce transfusion rates in major oncologic surgery: Results of a randomized, double‐blind, and placebo‐controlled trial

Abstract

Preoperative administration of tranexamic acid at a 1000 mg intravenous dose does not decrease transfusion rates or estimated blood loss in patients undergoing major oncologic surgery.